Mats Jerkeman

161 – 170 of 192

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/person/onk-mje?embed=1&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

2009
Mark Pre-Emptive Treatment With Rituximab of Molecular Relapse After Autologous Stem Cell Transplantation in Mantle Cell Lymphoma.
Andersen, Niels S ; Pedersen, Lone B ; Laurell, Anna ; Elonen, Erkki ; Kolstad, Arne ; Boesen, Anne Marie ; Pedersen, Lars M ; Lauritzsen, Grete F ; Ekanger, Roald and Nilsson-Ehle, Herman , et al. (2009) In Journal of Clinical Oncology 27. p.4365-4370
- Contribution to journal › Article
Mark Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA
Olofsson, S. ; Dahl, O. ; Jerkeman, Mats ^LU ; Cohn-Cedermark, G. ; Klepp, O. ; Stierner, U. ; Tornblom, M. ; Wahlqvist, R. and Cavallin-Ståhl, Eva ^LU (2009) 45th Annual Meeting of the American-Society-of-Clinical-Oncology In Journal of Clinical Oncology 27(15).
- Contribution to journal › Published meeting abstract
Mark Identification of molecular targets associated with transformed diffuse large B cell lymphoma using highly purified tumor cells.
Andreasson, Ulrika ^LU ; Dictor, Michael ^LU ; Jerkeman, Mats ^LU ; Berglund, Mattias ; Sundström, Christer ; Linderoth, Johan ^LU ; Rosenquist, Richard ; Borrebaeck, Carl ^LU and Ek, Sara ^LU (2009) In American Journal of Hematology 84. p.803-808
- Contribution to journal › Article
Mark Prognostic impact of activated B-cell focused classification in diffuse large B-cell lymphoma patients treated with R-CHOP
Nyman, Heidi ; Jerkeman, Mats ^LU ; Karjalainen-Lindsberg, Marja-Liisa ; Banham, Alison H. and Leppa, Sirpa (2009) In Modern Pathology 22(8). p.1094-1101
- Contribution to journal › Article
2008
Mark Sox11, a non-B cell lineage transcription factor, is overexpressed in mantle cell lymphoma
Dictor, Michael ^LU ; Ek, Sara ^LU ; Jerkeman, Mats ^LU ; Jirström, Karin ^LU and Borrebaeck, Carl ^LU (2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.172-173
- Contribution to journal › Published meeting abstract
Mark Genes associated with the tumour microenvironment are differentially expressed in cured versus primary chemotherapy-refractory diffuse large B-cell lymphoma.
Linderoth, Johan ^LU ; Edén, Patrik ^LU ; Ehinger, Mats ^LU ; Valcich, Jeanette ^LU ; Jerkeman, Mats ^LU ; Bendahl, Pär-Ola ^LU ; Berglund, Mattias ; Enblad, Gunilla ; Erlanson, Martin and Roos, Göran , et al. (2008) In British Journal of Haematology 141(4). p.423-432
- Contribution to journal › Article
Mark B cell lymphomas express CX(3)CR1 a non-B cell lineage adhesion molecule.
Andreasson, Ulrika ^LU ; Ek, Sara ^LU ; Merz, Hartmut ; Rosenquist, Richard ; Andersen, Niels ; Jerkeman, Mats ^LU ; Dictor, Michael ^LU and Borrebaeck, Carl A K (2008) In Cancer Letters 259(2). p.138-145
- Contribution to journal › Article
Mark Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group
Geisler, Christian H. ; Kolstad, Arne ; Laurell, Anna ; Andersen, Niels S. ; Pedersen, Lone B. ; Jerkeman, Mats ^LU ; Eriksson, Mikael ^LU ; Nordstrom, Marie ; Kimby, Eva and Boesen, Anne Marie , et al. (2008) In Blood 112(7). p.2687-2693
- Contribution to journal › Article
Mark R-CHOEP-14 X 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma (DLBCL)/Follicular Lymphoma (FL) Grade 3 with Age Adjusted IPI Score 2-3: Preliminary Results of a Nordic Lymphoma Group (NLG) Phase 2 Study Including 160 Patients Aged 18-64 Years.
Holte, Harald ; Leppa, Sirpa M. ; Bjorkholm, Magnus ; Fluge, Oystein ; Jyrkkio, Sirkku ; Delabie, Jan ; Sundstrom, Christer ; Karjalainen-Lindsberg, Marja-Liisa ; Erlanson, Martin and Kolstad, Arne , et al. (2008) 50th Annual Meeting of the American- Society-of-Hematology In Blood 112(11). p.1233-1233
- Contribution to journal › Published meeting abstract
Mark BCL-2 but not FOXP1, is an adverse risk factor in immunochemotherapy treated non-germinal center diffuse large B-cell lymphomas
Nyman, H ; Jerkeman, Mats ^LU ; Karjalainen-Lindsberg, M ; Banham, A ; Enblad, G and Leppa, S (2008) 10th International Conference on Malignant Lymphoma In Annals of Oncology 19(Suppl. 4). p.142-142
- Contribution to journal › Published meeting abstract